Oxygen‐Evolving Manganese Ferrite Nanovesicles for Hypoxia‐Responsive Drug Delivery and Enhanced Cancer Chemoimmunotherapy
- 20 January 2021
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 31 (11)
- https://doi.org/10.1002/adfm.202008078
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21871301)
This publication has 37 references indexed in Scilit:
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapiesNature Reviews Drug Discovery, 2019
- Fundamental Mechanisms of Immune Checkpoint Blockade TherapyCancer Discovery, 2018
- Bioinspired Hybrid Protein Oxygen Nanocarrier Amplified Photodynamic Therapy for Eliciting Anti-tumor Immunity and Abscopal EffectACS Nano, 2018
- Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)Journal for ImmunoTherapy of Cancer, 2018
- Nanoscale Metal–Organic Framework Overcomes Hypoxia for Photodynamic Therapy Primed Cancer ImmunotherapyJournal of the American Chemical Society, 2018
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and LimitationsFrontiers in Oncology, 2018
- Cancer immunotherapy using checkpoint blockadeScience, 2018
- Mechanisms of resistance to immune checkpoint inhibitorsBritish Journal of Cancer, 2018
- Primary, Adaptive, and Acquired Resistance to Cancer ImmunotherapyCell, 2017
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade TherapyImmunity, 2016